Home/ Supplements/ Vitamin K/ Liver, Heart & Kidney Support

Liver, Heart & Kidney Support

product on market Capsule Enhanced Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 88% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula contains ingredients like Hawthorn Berry and Grape Seed extracts, which have moderate evidence for supporting cardiovascular and antioxidant functions. Vitamin K2 and Garlic Bulb Extract are researched for their roles in bone health and lipid management. Overall, the evidence coverage for this specific combination of ingredients is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Liver, Heart & Kidney Support
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
88%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

400 mcg (332% DV)
3.3× RDA — above typical dose 275 studies (A:9, B:175)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
Market median: 333.0mg (166 products) 9 studies (A:0, B:2)
Market median: 250.0mg (562 products) 55 studies (A:0, B:19)
Market median: 320.0mg (426 products) 26 studies (A:0, B:5)
Policosanol
40 mg

Other Ingredients

Hypromellose Rice Flour Calcium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take four (4) capsules once daily with or without food.

Warnings & Precautions

Caution: Individuals with known medical conditions should consult a doctor before taking this or any dietary supplement.

Keep out of reach of children and don't use if safety seal is damaged or missing.

Formulation Notes

Hardcore formulas using clinical dosages backed by superhuman results

Additional Information

Store in a cool, dry place.

Made in USA with Global and Domestic Ingredients GMP Quality Good Manufacturing Practice Certification

Metadata

Product Details

UPC / SKU8 50046 97438 0
DSLD Entry Date2025-02-23
Product TypeOther Combinations
FormCapsule
BrandEnhanced
DSLD ID321433
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Natural Vitamin K2 45 mcg
Doctor's Best · Capsule
100
K 100 mcg
Thompson · Capsule
100
Vitamin K2 300 mcg MK-7
Innerzyme · Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Enhanced View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.